Article
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
Oncogene - 24 Aug 2000
Nieborowska-Skorska M, Slupianek A, Skorski T
Abstract excerpt
Our previous study indicated that BCR/ABL SH2 domain and BCR/ABL SH3 domain+SH2 domain complex are required for immediate activation of the phosphatidylinositol-3 kinase PI-3k)--> Akt serine/threonine kinase pathway and of the signal transducer and activator of transcription 5 (STAT5), respectively, in hematopoietic cells. We show here that the defect in activation of PI-3k/Akt by BCR/ABL DeltaSH2 mutant (SH2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
